|
|
Article: Hawaii Biotech Reports Phase 1 Results for West Nile Virus Vaccine.(Financial report)
- Article from:
- Vaccine Weekly
- Article date:
- March 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Hawaii Biotech, Inc., announced successful Phase 1 clinical trial results of its West Nile Virus vaccine in healthy volunteers. Hawaii Biotech is developing a West Nile recombinant sub-unit vaccine to induce protective immunity in recipients of the vaccine (see also Hawaii Biotech, Inc.).
The results demonstrated a favorable safety profile in 24 subjects across four cohorts. The Phase 1 study was designed as an ascending dose study to assess the safety of Hawaii BiotechEs West Nile Virus vaccine among healthy adult volunteers who had not been exposed to the West Nile or similar virus. The study also examined antibody development to the vaccine. The overall ...